181 related articles for article (PubMed ID: 1718602)
1. Review of neuromuscular blockers.
Whittaker R; Wedell D
Compendium; 1991 Jun; 12(6):408, 410, 412 passim. PubMed ID: 1718602
[TBL] [Abstract][Full Text] [Related]
2. [Complications of relaxants].
Mignen J
Cah Anesthesiol; 1971 Nov; 19(7):911-6. PubMed ID: 4110548
[No Abstract] [Full Text] [Related]
3. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
Nguyen A; Ramzan I
Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879
[No Abstract] [Full Text] [Related]
4. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.
Booij LH
Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750
[TBL] [Abstract][Full Text] [Related]
5. [Specificity of pharmacological trials and the idea of target structures].
Valette G
Biol Med (1971); 1974 Jun; 3(1):1-19. PubMed ID: 4157176
[No Abstract] [Full Text] [Related]
6. Muscle relaxants suitable for day case surgery.
Geldner G; Wulf H
Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of neuromuscular blockers and their antagonists.
Naguib M; Magboul MM
Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339
[TBL] [Abstract][Full Text] [Related]
8. Options on the use of muscle relaxants in clinical anaesthesia.
Vilardi V
Minerva Anestesiol; 2001 Mar; 67(3):91-5; discussion 95-6. PubMed ID: 11337640
[No Abstract] [Full Text] [Related]
9. Pharmacology of neuromuscular blocking agents in the intensive care unit.
Hanson CW
Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on histamine liberating actions of muscle relaxants].
Miyashita K
Masui; 1975 May; 24(5):451-62. PubMed ID: 51104
[No Abstract] [Full Text] [Related]
11. Muscle relaxants in paediatric day case surgery.
Meakin GH
Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
[TBL] [Abstract][Full Text] [Related]
12. The use of neuromuscular blocking agents to investigate receptor structure requirements for histamine release.
Buckett WR; Frisk-Holmberg M
Br J Pharmacol; 1970 Sep; 40(1):165P-166P. PubMed ID: 4098852
[No Abstract] [Full Text] [Related]
13. [Neuromuscular blockades. Agents, monitoring and antagonism].
Schreiber JU; Fuchs-Buder T
Anaesthesist; 2006 Nov; 55(11):1225-35; quiz 1236. PubMed ID: 17082884
[TBL] [Abstract][Full Text] [Related]
14. Severe drug reactions during anaesthesia.
Bird AG
Adverse Drug React Acute Poisoning Rev; 1987; 6(3):117-40. PubMed ID: 2447764
[No Abstract] [Full Text] [Related]
15. The depolarizing and non-depolarizing neuromuscular blocking agents.
Lamid S; Wang RI
Wis Med J; 1974 Jan; 73(1):S15-6. PubMed ID: 4273039
[No Abstract] [Full Text] [Related]
16. The neuromuscular blocking drugs.
Torda TA
Med J Aust; 1988 Sep; 149(6):316-9. PubMed ID: 2843731
[No Abstract] [Full Text] [Related]
17. Clinical assessment of neuromuscular transmission.
Viby-Mogensen J
Br J Anaesth; 1982 Feb; 54(2):209-23. PubMed ID: 6277354
[No Abstract] [Full Text] [Related]
18. [Side-effects of the curare-like agents].
Lévy D; Lecron L
Anesth Analg (Paris); 1973; 30(5):911-28. PubMed ID: 4135404
[No Abstract] [Full Text] [Related]
19. The neuromuscular blocking actions of pancuronium.
Norman J; Katz RL; Seed RF
Anaesthesia; 1970 Jan; 25(1):130. PubMed ID: 4244174
[No Abstract] [Full Text] [Related]
20. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
Schuh FT
Klin Anasthesiol Intensivther; 1980; 22():158-74. PubMed ID: 6108384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
